Mindfulness-Based Cognitive Therapy as an Intervention for Migraine

Not Applicable

• Conditions: G43.0; G43.1; Migraine without aura [common migraine]; Migraine with aura [classical migraine]

• Registration Number: DRKS00007477
• Lead Sponsor: Sektion Komplementärmedizinische Evaluationsforschung,Zentrum für Psychische Erkrankungen, Klinik für Psychosomatische

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11-24
• Study Completion: 2016-01-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Inclusion criteria are as follows:
- The presence of migraine since at least six months
- The presence of an average migraine frequency of at least two attacks per months. At least one of these two attacks should last more than a day.
- Konstant dose of a pharmacological prophylaxis (.i.e. Propanolol, Metoprolol, Topiramat und Flunarizin) over three month prior to start of the study
- Willingness to accept the requirements of the intervention

Exclusion Criteria

In addition we defined the following exclusion criteria:
- The presence of a life-threatening disease as well as presence of severe psychiatric disorders and/or
addiction which seriously hinder interpersonal contact
- Overuse of acute migraine medication potentially posing the risk of medication-induced headache (i.e.
consumption of triptans on more of 10 day per months and consumption of simple analgetics on more than 15 days per month)
- Intention to start another pain treatment or a psychotherapy or to participate in other clinical studies during the duration of the trial
- Having a regular practice of meditation (> 1x per week) or Yoga (> 2x per week) as well as having
participated in a MBSR- or MBCT-intervention

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
migraine related disability assessed by headache diaries for three times for 4 weeks (intervention group: pre, post, 9-months-follow-up from baseline; control group: pre and post according to the waiting period and post2 according to the intervention that followed) by means of an eleven-scale numerical analogue scale (no impairment - complete impairment)